BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo R, Delaunay-Moisan A, Timmis K, Danchin A. SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done. Environ Microbiol 2021;23:2339-63. [PMID: 33769683 DOI: 10.1111/1462-2920.15487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rey F. Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern. C R Biol 2021;344:77-110. [PMID: 34213849 DOI: 10.5802/crbiol.53] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Fernández-Lázaro D, Garrosa M. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. Viruses 2021;13:1916. [PMID: 34696346 DOI: 10.3390/v13101916] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Akram F, Haq IU, Aqeel A, Ahmed Z, Shah FI, Nawaz A, Zafar J, Sattar R. Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review. J Virol Methods 2022;300:114375. [PMID: 34838536 DOI: 10.1016/j.jviromet.2021.114375] [Reference Citation Analysis]
4 Gallais F, Pible O, Gaillard JC, Debroas S, Batina H, Ruat S, Sandron F, Delafoy D, Gerber Z, Olaso R, Gas F, Bellanger L, Deleuze JF, Grenga L, Armengaud J. Heterogeneity of SARS-CoV-2 virus produced in cell culture revealed by shotgun proteomics and supported by genome sequencing. Anal Bioanal Chem 2021. [PMID: 34013402 DOI: 10.1007/s00216-021-03401-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tosta E. The adaptation of SARS-CoV-2 to humans. Mem Inst Oswaldo Cruz 2022;116:e210127. [PMID: 35019068 DOI: 10.1590/0074-02760210127] [Reference Citation Analysis]
6 Ozsahin DU, Gelisen MI, Taiwo M, Agachan Y, Rahi D, Uzun B. Decision Analysis of the COVID-19 Vaccines. The EuroBiotech Journal 2021;5:20-5. [DOI: 10.2478/ebtj-2021-0017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Weinstein JB, Bates TA, Leier HC, McBride SK, Barklis E, Tafesse FG. A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants. iScience 2022;:103960. [PMID: 35224467 DOI: 10.1016/j.isci.2022.103960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mahmoodpoor A, Sanaie S, Samadi P, Yousefi M, Nader ND. SARS-CoV-2: Unique Challenges of the Virus and Vaccines. Immunol Invest 2021;:1-8. [PMID: 34109900 DOI: 10.1080/08820139.2021.1936009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]